The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Inhalation CDMO Market Between 2026 And 2030?
The inhalation cdmo market size has experienced strong growth in recent years. It is anticipated to increase from $2.2 billion in 2025 to $2.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. The expansion observed historically can be linked to the rising prevalence of asthma and copd, a growing demand for inhalation therapies, the development of biologics and specialized drug formulations, progress in formulation technologies, and an increase in outsourcing by pharmaceutical companies.
The inhalation cdmo market size is anticipated to undergo significant expansion in the upcoming years. Its value is projected to reach $3.03 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.6%. This expected growth is primarily fueled by the increasing prevalence of digital and smart inhalers, the evolution of personalized medicine and precision therapy, heightened investment in inhalation cdmo infrastructure, the growing adoption of advanced manufacturing technologies, and a rise in collaborations between biotech firms and cdmos. Prominent trends for this forecast period involve the development of personalized inhalation therapies, sophisticated formulation and drug delivery techniques, enhancements in regulatory compliance and quality assurance, the widening of contract manufacturing opportunities for small and medium-sized businesses, and the integration of smart inhalers with digital health monitoring.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13864&type=smp
What Major Drivers Are Influencing Demand In The Inhalation CDMO Market?
A growing occurrence of respiratory disorders is anticipated to stimulate the expansion of the inhalation CDMO market moving forward. Respiratory disorders are a collection of medical conditions that impact the respiratory system, encompassing the organs and structures involved in breathing. Inhalation CDMOs are utilized in the development and manufacturing of products designed for respiratory disorders, owing to their specialized knowledge in formulating and delivering drugs to the lungs, and offering dedicated expertise, infrastructure, and resources to pharmaceutical companies seeking to introduce innovative inhalation therapies. For instance, in December 2023, according to the National Library of Medicine, a US-based medical library, the global number of chronic obstructive pulmonary disease (COPD) cases among those 25 and older is projected to rise by 23% by 2050, reaching nearly 600 million. Consequently, the increasing prevalence of respiratory disorders is fueling the growth of the inhalation CDMO market.
Which Market Segments Are Examined In The Inhalation CDMO Market Study?
The inhalation cdmo market covered in this report is segmented –
1) By Product: Dry Powder Inhaler (DPIs), Metered Dose Inhaler (MDIs), Nebulizer, Soft Mist Inhaler
2) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Acute Respiratory Distress Syndrome, Pulmonary Fibrosis
3) By Technology: Manual Inhalers (SMI), Digital Inhalers
4) By End-User: Big Pharmaceutical Companies, Small and Medium-sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End-Users
Subsegments:
1) By Dry Powder Inhaler (DPIs): Capsule-Based DPIs, Diskus-Style DPIs, Multi-Dose DPIs, Unit-Dose DPIs
2) By Metered Dose Inhaler (MDIs): Pressurized MDIs (pMDIs), Breath-Actuated MDIs, Soft Mist MDIs
3) By Nebulizer: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers, Portable Nebulizers
4) By Soft Mist Inhaler: Respimat Inhalers, Other Soft Mist Inhalation Devices
Which Trends Are Influencing The Inhalation CDMO Market?
Leading companies in the inhalation CDMO industry are increasingly forming strategic partnerships to deliver specialized drug development and delivery solutions. A strategic partnership involves a long-term, mutually beneficial agreement between two or more firms collaborating to achieve common objectives. For instance, in May 2023, Hovione, a Contract Development and Manufacturing Organization based in Portugal, entered into a partnership with H&T Presspart, a UK-based producer of high-precision metal and plastic components for the pharmaceutical sector, to advance Presspart’s Sunrise Capsule-based Dry Powder Inhaler platform. This collaboration aims to develop new technologies that can administer higher drug doses and enhance the efficiency of drug delivery to the lungs.
Who Are The Primary Competitors In The Inhalation CDMO Market?
Major companies operating in the inhalation cdmo market are Baxter’s BioPharma Solutions, Lonza Group AG, Catalent Inc., Siegfried Holding AG, Recipharm AB, Stevanato Group SpA, CordenPharma, Nemera, Hovione FarmaCiencia SA, Vectura Group Ltd., CARBOGEN AMCIS, Kindeva Drug Delivery Ltd., Frontage Laboratories Inc, Sanner GmbH, H&T Presspart Ltd., Astech Projects Ltd, Cliantha Research, Copley Scientific, Cambrex Corporation, AptarGroup Inc.
Read the full inhalation cdmo market report here:
https://www.thebusinessresearchcompany.com/report/inhalation-cdmo-global-market-report
Which Region Shows The Strongest Potential For Future Growth In The Inhalation CDMO Market?
North America was the largest region in the inhalation contract development and manufacturing organization (CDMO) market in 2025. The regions covered in the inhalation cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Inhalation CDMO Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13864&type=smp
Browse Through More Reports Similar to the Global Inhalation CDMO Market 2026, By The Business Research Company
Inhalation Cdmo Market Report 2026
https://www.thebusinessresearchcompany.com/report/inhalation-cdmo-global-market-report
Inhalable Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/inhalable-drugs-global-market-report
Inhalation Anesthesia Market Report 2026
https://www.thebusinessresearchcompany.com/report/inhalation-anesthesia-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model